PATH | VRL
Menu

Find resources

Total results with these characteristics: 50

Region: Latin America and the Caribbean

Page 1 of 2
Access to Vaccine Technologies in Developing Countries: Brazil and India

The authors of this study, published in the journal Vaccine, analyzed advantages and disadvantages of different ways vaccine manufacturers access new technologies. Among the methods considered were collaborations with academia and research …

Author: Milstien J, Gaule G, Kaddar M

Publication date: 2007

Association Between Pentavalent Rotavirus Vaccine and Severe Rotavirus Diarrhea Among Children in Nicaragua

This article, published in the Journal of the American Medical Association, summarizes the first study to assess the impact of rotavirus vaccination in a developing country. The authors concluded that the vaccine could have a substantial impact on …

Author: Patel M, Pedreira C, De Oliveira LH, et al.

Publication date: 2009

The Burden of Pneumococcal Disease Among Latin American and Caribbean Children: Review of the Evidence

This article, published in the Pan American Journal of Public Health, estimates the annual burden of pneumonia, meningitis, and acute otitis media caused by pneumococcus in children less than five years of age in Latin America and the …

Author: Valenzuela MT, O'Loughlin R, De La Hoz F, et al.

Publication date: 2009

The Burden of Pneumococcal Disease and Cost-Effectiveness of a Pneumococcal Vaccine in Latin America and the Caribbean: A Review of the Evidence and a Preliminary Economic Analysis

This report estimates the burden and costs of pneumococcal disease in Latin America and the Caribbean in order to inform national health authorities about disease burden and the economic value of implementing a pneumococcal …

Author: Sabin Vaccine Institute

Publication date: 2007

A Case for Better Immunization Information Systems

This evidence brief discusses the rationale for improving immunization information systems and describes user experiences with different types of systems. It also provides advice on feasibility in different contexts. It draws on evidence gathered …

Author: PATH, World Health Organization

Publication date: 2013

Cervical Cancer Screening and Treatment in Low-Resource Settings: Practical Experience From PATH

From 2006 to 2011, PATH conducted human papillomavirus (HPV) vaccination demonstration projects in India, Peru, Uganda, and Vietnam to provide evidence for decision-making about public-sector introduction of HPV vaccines. This report examines the …

Author: PATH

Publication date: 2013

Childhood Immunization: What You Need to Know

Information for parents and health care workers about diseases and vaccines, extensive questions and answers, and charts comparing disease risk versus vaccine risk.

Author: PATH

Publication date: 2004

Collaborating With Countries to Improve Supply Chains

Optimize—a collaboration between the World Health Organization and PATH—aims to employ technological and scientific advances by defining ideal specifications for health products and creating a flexible and robust vaccine supply chain that can …

Author: PATH; World Health Organization

Publication date: 2010

Community Diarrhea Incidence Before and After Rotavirus Vaccine Introduction in Nicaragua

This article, published in the American Journal of Tropical Medicine and Hygiene, reports on a study that compared the incidence of diarrhea before and after the introduction of the pentavalent rotavirus vaccine in Leon, Nicaragua. The results …

Author: Becker-Dreps S, Meléndez M, Liu L, et al.

Publication date: 2013

Comprehensive Family Immunization (IM)

This web page on the Pan American Health Organization's website provides information about the IM initiative. The mission of this initiative is to promote and coordinate technical cooperation and partnerships with the private and public sectors and …

Author: Pan American Health Organization

Publication date: 1111

Cost-Effectiveness of Introducing a Rotavirus Vaccine in Developing Countries: The Case of Mexico

This study, published in BMC Infectious Diseases, developed a model to compare the cost and disease burden of rotavirus in unvaccinated children in Mexico. The study determined that it would be highly cost-effective to include rotavirus vaccine …

Author: Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R

Publication date: 2008

Diarrhoea-Related Hospitalizations in Children Before and After Implementation of Monovalent Rotavirus Vaccination in Mexico

This article, published in the Bulletin of the World Health Organization, reports on a study that compared the incidence of diarrhea in young children before and after the national introduction of monovalent rotavirus vaccine in Mexico. The results …

Author: Esparza-Aguilar M, Gastañaduy PA, Sánchez-Uribe E, et al.

Publication date: 2014

Duration of Protection of Pentavalent Rotavirus Vaccination in Nicaragua

This article, published in Pediatrics, summarizes a case-control study conducted at four hospitals in Nicaragua to evaluate the duration of protection after rotavirus vaccination among eligible infants. The pentavalent rotavirus vaccine …

Author: Patel M, Pedreira C, De Oliveira LH, et al.

Publication date: 2012

Economic Impact of a Rotavirus Vaccination Program in Mexico

This article, published in the Pan American Journal of Public Health, examines a national rotavirus vaccination program in Mexico and evaluates its costs and benefits. The article concludes that the program would be highly cost-effective and …

Author: Constenla D, Velázquez FR, Rheingans RD, Antil L, Cervantes Y

Publication date: 2009

Effect of Rotavirus Vaccination on Death From Childhood Diarrhea in Mexico

This article, published in The New England Journal of Medicine, discusses a study on the effectiveness of rotavirus vaccine in Mexico. The study examined the impact of vaccination on diarrheal deaths in Mexican children between 2008 and 2009 …

Author: Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al.

Publication date: 2010

Effect of Rotavirus Vaccine on Diarrhea Mortality in Different Socioeconomic Regions of Mexico

This article, published in Pediatrics, concludes that after the 2007 introduction of rotavirus vaccine in Mexico, marked and sustained declines in diarrhea deaths were seen among children in all regions of the country, including in the least …

Author: Gastañaduy PA, Sánchez-Uribe E, Esparza-Aguilar M, et al.

Publication date: 2013

Effectiveness of Monovalent Rotavirus Vaccine in Bolivia: Case-Control Study

This article, published in BMJ, reports on a study that evaluated the effectiveness of two doses of a monovalent rotavirus vaccine against hospital admission for rotavirus at six hospitals in Bolivia, between March 2010 and June 2011. Results show …

Author: Patel MM, Patzi M, Pastor D, et al.

Publication date: 2013

Enterotoxigenic Escherichia coli in Developing Countries: Epidemiology, Microbiology, Clinical Features, Treatment, and Prevention

This article was published in Clinical Microbiology Reviews. ETEC is an underrecognized but extremely important cause of diarrhea in the developing world where there is inadequate clean water and poor sanitation. It is the most frequent bacterial …

Author: Qadri F, Svennerholm AM, Faruque AS, Sack RB

Publication date: 2005

Epidemiology of Meningococcal Disease in Latin America: Current Situation and Opportunities for Prevention

This article, published in Neurological Research, discusses the changes in the epidemiology of meningococcal disease in Latin America and comments on the development and potential impact of new vaccines for the prevention of the disease. The authors …

Author: Sáfadi MA, Cintra OA

Publication date: 2010

Evaluaciónde Costo-Efectividad de la Vacuna Anti-rotavirus en Chile

This article, published in Revista Médica de Chile, outlines an economic model that determined rotavirus vaccination is a cost-effective intervention that can effectively reduce the disease burden and healthcare costs of rotavirus …

Author: Constenla D, O'Ryan M, Navarrete M, Antil L, Rheingans R

Publication date: 2006

Evaluating HPV Vaccination Pilots: Practical Experience From PATH

From 2006 to 2011, PATH conducted human papillomavirus (HPV) vaccination demonstration projects in India, Peru, Uganda, and Vietnam to provide evidence for decision-making about public-sector introduction of HPV vaccines. This report provides …

Author: PATH

Publication date: 2012

Evolution of Streptococcus Pneumoniae Serotypes and Penicillin Susceptibility in Latin America, Sireva-Vigia Group, 1993-1999

Since 1993 the Pan American Health Organization has coordinated a surveillance network with the National Reference Laboratories of Argentina, Brazil, Chile, Colombia, Mexico and Uruguay aimed at monitoring capsular types and antimicrobial …

Author: Di Fabio JL, Castañeda E, Agudelo CI, et al.

Publication date: 2001

Guía Práctica de Vacunación

This Argentinean website provides information about vaccine preventable diseases and is a professional, independent site run by Carlos Kohler. It includes international and Argentinean news and information and is the online Practical Guide to …

Author: Dr. Carlos Kohler

Publication date: 1111

HPV Vaccination in Latin America: Lessons Learned From a Pilot Program in Peru

This report summarizes a human papillomavirus (HPV) vaccination program implemented in Peru where HPV vaccine was made available to all girls aged nine years or older in fifth grade in selected parts of the country. The purpose of the study was to …

Author: PATH, Instituto de Investigación Nutricional, Ministerio de Salud de Peru, Estrategia Sanitaria Nacional de Inmunizaciones

Publication date: 2010

Human Papillomavirus Vaccine Delivery Strategies That Achieved High Coverage in Low- and Middle-Income Countries

This article, published in the Bulletin of the World Health Organization, documents human papillomavirus (HPV) vaccination coverage after the demonstration projects conducted in India, Peru, Uganda, and Vietnam by PATH and national governments. …

Author: LaMontagne DS, Barge S, Nga TL, et al.

Publication date: 2011

Page 1 of 2